The meeting served as a valuable platform for discussions on enhancing early disease detection and improving access to preventive healthcare services, in line with PERKESO's ongoing commitment to safeguarding the health and wellbeing of its members.
On 10 June 2026, MyRNA participated in a strategic engagement session with the Social Security Organisation (PERKESO) in Putrajaya, aimed at exploring innovative healthcare solutions that strengthen preventive health initiatives for Malaysia's workforce.
The meeting served as a valuable platform for discussions on enhancing early disease detection and improving access to preventive healthcare services, in line with PERKESO's ongoing commitment to safeguarding the health and wellbeing of its members. By fostering collaboration with healthcare innovators, the organisation continues to identify solutions that can contribute to better long-term health outcomes and reduce the burden of serious diseases through early intervention.
During the engagement, MyRNA introduced LUNGClear, its non-invasive molecular screening solution designed to support the early detection of individuals who may be at an increased risk of lung cancer. The proposal highlighted the potential integration of LUNGClear into PERKESO's preventive health screening initiatives, particularly for members with elevated risk factors such as advancing age, smoking history, occupational exposure to hazardous substances, or other relevant clinical risk factors.
By enabling earlier identification of individuals who may benefit from further clinical assessment, LUNGClear has the potential to complement existing screening strategies and support more timely medical intervention. The solution reflects MyRNA's commitment to advancing precision diagnostics through innovative technologies that make preventive healthcare more accessible and impactful.
MyRNA appreciates the opportunity to engage with PERKESO and share its vision for strengthening preventive healthcare through molecular diagnostics. The discussion represents an important step towards fostering collaborative efforts that enhance public health, improve early detection strategies, and ultimately contribute to better health outcomes for Malaysian workers and their families.
As MyRNA continues to expand partnerships across the healthcare ecosystem, the company remains committed to delivering innovative diagnostic solutions that support national healthcare priorities and promote a future where early detection becomes an integral part of preventive care.
